Skip to main content
# Title Research Year
81 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
82 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
83 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
84 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
85 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
86 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
87 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
88 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
89 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules
with Chemotherapy: A Retrospective Comparative Study
2017
90 Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. 2017